Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.870
+0.170 (4.59%)
Dec 5, 2025, 2:25 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 103.95 million as of December 5, 2025. Its market cap has increased by 91.46% in one year.
Market Cap
103.95M
Enterprise Value
156.62M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.87
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 103.95M, a decrease of -84.44%. That is a compound annual growth rate of -32.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 99.38M | 114.06% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.66B |
| Nordhealth AS | 2.91B |
| Photocure ASA | 1.71B |
| Thor Medical ASA | 1.50B |
| ArcticZymes Technologies ASA | 1.02B |
| Omda AS | 1.00B |
| Vistin Pharma ASA | 878.02M |
| Gentian Diagnostics ASA | 848.23M |